Humalog Vial u100-8vials
Humalog Vial u100-8vials
Buy Humalog Vial, Humalog Vial for sale
Buy Humalog Vial, Insulin Humalog from the French manufacturer ELI LILLY VOSTOK, S.A., is a medication for patients with diabetes mellitus. The active substance for the drug is insulin lispro, DNA recombinant human fast-acting insulin analog. The other excipients include glycerol (glycerin) – 16 mg, metacresol – 3.15 mg, zinc oxide (q.s. for Zn2 + 0.0197 μg content), sodium hydrogen phosphate heptahydrate – 1.88 mg, hydrochloric acid solution 10% and/or sodium hydroxide solution 10% – q.s. up to pH 7.0-8.0, water – q.s. up to 1 ml.
The concentration of insulin lispro in the injectable solution Insulin Humalog is 100 units/ml.
The main action of the drug is the regulation of glucose metabolism. In addition, it has an anabolic effect.
In patients with diabetes mellitus types 1 and 2, with the use of Humalog insulin lispro, hyperglycemia that occurs after meals is significantly reduced in comparison with soluble human insulin. For patients on basal and short-acting insulin, the dose of both short- and long-acting insulin must be adjusted to achieve optimal blood glucose levels throughout the day.
You can buy Insulin Humalog Vial 10ml from us. Please note that to place an order, you will need a valid prescription from your health care provider.
Find out more helpful information about the Humalog sliding scale for better blood sugar control.
Buy Humalog Vial Dosage
The doctor determines the dose individually, depending on the patient’s needs. It also depends on his/her diet, physical activity, and lifestyle. Humalog can be administered shortly before a meal, if necessary – immediately after a meal.
Humalog is administered subcutaneously in the form of injections or as an extended subcutaneous infusion using an insulin pump. If necessary (ketoacidosis, acute diseases, the period between operations, or the postoperative period), Humalog can be administered intravenously.
Humalog insulin lispro injection should be administered into the shoulder, thigh, buttocks, or abdomen. The injection sites should be alternated in such a way that the same site is used no more than once a month. With subcutaneous administration of the drug Humalog®, care must be taken to avoid getting the drug into the blood vessel. After the procedure, do not massage the site of the injection.
Administration of the Drug Humalog
The solution of the drug Humalog must be transparent and colorless. Do not use a cloudy, thickened, or weakly colored solution of the drug or if solid particles are visually detected in it.
Intravenous injection of the drug Humalog should be carried out in accordance with normal clinical practice for intravenous administration with an infusion pump, for example, intravenous bolus administration or using an infusion system. This requires frequent monitoring of blood glucose levels.
Preparation and administration
- Wash your hands.
- Choose a site for injection.
- Treat the skin at the site of administration with an antiseptic.
- Remove the cap from the needle.
- Secure the skin by pulling it or pinching a large fold. Insert the needle in accordance with the instructions for use of the syringe pen.
- Perform the injection.
- Remove the needle and gently press the injection site for a few seconds. Do not rub.
- Using the needle shield, unscrew the needle and discard it.
- The injection sites should be changed in such a way that the same site is used no more than about 1 time per month.